Evidence map›Paper›PMID 25864934›Full record

ArticleJournal of virological methods2015

Development of a non-infectious encapsidated positive control RNA for molecular assays to detect foot-and-mouth disease virus.

Mikidache Madi, Valerie Mioulet, Donald P King, George P Lomonossoff, Nicholas P Montague

Abstract readEvaluation Study
In one paragraph

Article in Journal of virological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Frontiers in plant science · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mikidache MadiThe Pirbright Institute, Ash Road, Pirbright GU24 0NF, Surrey, United Kingdom. Electronic address: miki.madi@pirbright.ac.uk.
Valerie MiouletThe Pirbright Institute, Ash Road, Pirbright GU24 0NF, Surrey, United Kingdom. Electronic address: valerie.mioulet@pirbright.ac.uk.
Donald P KingThe Pirbright Institute, Ash Road, Pirbright GU24 0NF, Surrey, United Kingdom. Electronic address: donald.king@pirbright.ac.uk.
George P LomonossoffDepartment of Biological Chemistry, John Innes Centre, Colney Lane, Norwich NR4 7UH, United Kingdom. Electronic address: george.lomonossoff@jic.ac.uk.
Nicholas P MontagueDepartment of Biological Chemistry, John Innes Centre, Colney Lane, Norwich NR4 7UH, United Kingdom. Electronic address: nicholas.montague@jic.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/J004596/1Biotechnology and Biological Sciences Research Council BB/K01093X/1Biotechnology and Biological Sciences Research Council BBS/E/J/000CA326
6 · The paper itself

Abstract

Positive controls are an important component of the quality-control of molecular tests used for diagnosis of livestock diseases. For high consequence agents such as foot-and-mouth disease virus (FMDV), the positive controls required to monitor template extraction, reverse transcription and amplification steps usually consist of material derived from infectious viruses. Therefore, their production is dependent upon the use of high containment facilities and their deployment carries the risks associated with inactivation of "live" FMDV. This paper describes the development of a novel non-infectious positive control that encodes FMDV RNA sequences that are encapsidated within Cowpea mosaic virus (CPMV) particles. This surrogate RNA has been engineered to contain sequences from the 5'UTR and 3D regions of FMDV targeted by many molecular assays (conventional RT-PCR, real-time RT-PCR and RT-LAMP). These sequences were inserted into a movement-deficient version of CPMV RNA-2 which is rescued from cowpea plants (Vigna unguiculota) by inoculation with RNA-1. In order to evaluate the performance of these encapsidated RNAs, nucleic acid prepared from a 10-fold dilution series was tested using a range of molecular assays. Results generated by using the molecular assays confirmed RNA-dependent amplification and the suitability of these particles for use in a range of diagnostic tests. Moreover, these CPMV particles were highly stable for periods of up to 46 days at room temperature and 37 °C. Recombinant CPMV can be used to produce high yields of encapsidated RNAs that can be used as positive and negative controls and standards in molecular assays. This approach provides a surrogate that can be potentially used outside of containment laboratories as an alternative to inactivated infectious virus for molecular diagnostic testing.

Indexed as

Reference StandardsAnimalsComovirusFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusMolecular Diagnostic TechniquesRNA, ViralTemperatureRNA, ViralCowpea mosaic virusDiagnosticsFoot-and-mouth disease virusPositive controlRNA

Identifiers

PMID25864934
PMCPMC4451496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.